NASDAQ:BTTC Black Titan Q1 2026 Earnings Report $0.97 +0.02 (+2.14%) Closing price 04:00 PM EasternExtended Trading$0.97 +0.00 (+0.28%) As of 07:46 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. ProfileEarnings HistoryForecast Black Titan EPS ResultsActual EPS-$1.81Consensus EPS N/ABeat/MissN/AOne Year Ago EPSN/ABlack Titan Revenue ResultsActual RevenueN/AExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/ABlack Titan Announcement DetailsQuarterQ1 2026Date2/18/2026TimeAfter Market ClosesConference Call DateN/AConference Call TimeN/AConference Call ResourcesEarnings HistoryCompany Profile Black Titan Earnings HeadlinesBlack Titan (NASDAQ:BTTC) Trading Down 1.9% - Here's WhyMay 29, 2026 | americanbankingnews.comBlack Titan Corp: Institutional Infrastructure Note: The Convergence of Pre-IPO Equity, Agentic Finance, and Neobank ChartersMay 12, 2026 | finanznachrichten.deThe roadshow starts Monday. This stock isn't ready.The SpaceX roadshow kicks off June 8. Goldman Sachs, the lead underwriter, will present the full S-1 to the world's largest fund managers - including a section naming one small company Musk's Colossus cannot operate without. Right now, most fund managers have never heard of it. By Friday, every one of them will. Dylan Jovine has identified the name and ticker before $75 billion in new capital starts chasing the SpaceX supply chain.June 4 at 1:00 AM | Behind the Markets (Ad)Black Titan Corp: Institutional Digital Asset Infrastructure: The Maturation of Yield Routing and Restaking RailsApril 22, 2026 | finanznachrichten.deBlack Titan Corp: Crypto Payments Sector Advances as Managed Stablecoin Rails Launch, Merchant Use Cases Expand, and Regulatory Frameworks TightenApril 18, 2026 | finanznachrichten.deBlack Titan Corporation Registered ShsApril 17, 2026 | markets.businessinsider.comSee More Black Titan Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Black Titan? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Black Titan and other key companies, straight to your email. Email Address About Black TitanTitan Pharmaceuticals, Inc. is a biopharmaceutical company developingproprietary therapeutics for the treatment of central nervous system disorders, cancer, and other serious and life threatening diseases. In the central nervous system arena, the company is developing iloperidone, which is clinical testing for schizophrenia through a licensing and development agreement with Novartis Pharma AG. Novartis has tradenamed the product Zomaril.View Black Titan ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles The Great AI Server Rotation Puts Hewlett Packard Enterprise and Super Micro Computer in FocusMedtronic Bottoms, Healthy Rebound AheadFrom Runway to Riches: Victoria's Secret's New LookDell's AI Toll Bridge Is Paved with Record MarginsGitLab’s Price Recovery Gains Traction—Time to Get On Board?Ulta's Q1 Report Primes It for a Beauty of a ReboundPalo Alto Networks Accelerates Growth 31% on AI Demand Upcoming Earnings Oracle (6/10/2026)Adobe (6/11/2026)Accenture (6/18/2026)FedEx (6/23/2026)Micron Technology (6/24/2026)NIKE (6/30/2026)Delta Air Lines (7/9/2026)Fastenal (7/13/2026)Bank of America (7/14/2026)The Goldman Sachs Group (7/14/2026) Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
